New African American Multiple Myeloma Facebook Group
Join the new Facebook African American Multiple Myeloma Group Today
Multiple myeloma is a rare blood cancer, but for African Americans it is more common. If you are African American or know a family member or friend who is, you can share this information on Facebook, which could lead to earlier diagnosis and longer life. Here are some important facts:
More African Americans are Diagnosed with Multiple Myeloma Than Other Ethnicities
African Americans are two times as likely to be diagnosed with it than white Americans. This is 1 out of ever 5 patients diagnosed with multiple myeloma. We don't yet understand why this is.
African Americans are Diagnosed with Myeloma at Younger Ages
African Americans are diagnosed with multiple myeloma at a younger age than white Americans.
- 66 years: Average age at diagnosis for African Americans
- 70 years: Average age at diagnosis for white Americans
African Americans Have Lower Risk Myeloma Genetics
Some studies show that the type of multiple myeloma found affecting African Americans may be lower risk and less aggressive than the type found in white Americans. This is identified by studying the genes found on the myeloma cells in different ethnic populations. This should mean that African Americans are living longer with multiple myeloma, but today they are not. We want that to change.
Learn More in the new African American Multiple Myeloma Facebook Group
The Myeloma Crowd is introducing a new Facebook group where we will be sharing news and information specifically for the African American community. Please share this new group with those you love who may benefit from better education, earlier treatment and access to important resources.
Join the new Facebook African American Multiple Myeloma Group Today
Join the new Facebook African American Multiple Myeloma Group Today
Multiple myeloma is a rare blood cancer, but for African Americans it is more common. If you are African American or know a family member or friend who is, you can share this information on Facebook, which could lead to earlier diagnosis and longer life. Here are some important facts:
More African Americans are Diagnosed with Multiple Myeloma Than Other Ethnicities
African Americans are two times as likely to be diagnosed with it than white Americans. This is 1 out of ever 5 patients diagnosed with multiple myeloma. We don't yet understand why this is.
African Americans are Diagnosed with Myeloma at Younger Ages
African Americans are diagnosed with multiple myeloma at a younger age than white Americans.
- 66 years: Average age at diagnosis for African Americans
- 70 years: Average age at diagnosis for white Americans
African Americans Have Lower Risk Myeloma Genetics
Some studies show that the type of multiple myeloma found affecting African Americans may be lower risk and less aggressive than the type found in white Americans. This is identified by studying the genes found on the myeloma cells in different ethnic populations. This should mean that African Americans are living longer with multiple myeloma, but today they are not. We want that to change.
Learn More in the new African American Multiple Myeloma Facebook Group
The Myeloma Crowd is introducing a new Facebook group where we will be sharing news and information specifically for the African American community. Please share this new group with those you love who may benefit from better education, earlier treatment and access to important resources.
Join the new Facebook African American Multiple Myeloma Group Today
about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation.
More on Treatment Advances
Trending Articles
Upcoming Events
Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.